# OnCo record thierry-facon (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/thierry-facon/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "thierry-facon" ;
  schema:name "Thierry Facon"@en ;
  schema:description "Led MAIA, which made daratumumab-lenalidomide-dexamethasone the standard for older patients with myeloma."@en ;
  schema:url <https://onco.cc/people/thierry-facon/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Facon%20T%5BAuthor%5D%20myeloma%20daratumumab%20MAIA> ;
  onco:tag "myeloma", "older-patients", "trialist" ;
  schema:jobTitle "Professor of Hematology, Lille University Hospital (CHU Lille)" ;
  onco:cancers <https://onco.cc/cancers/multiple-myeloma/> ;
  onco:technologies <https://onco.cc/technologies/monoclonal-antibody/> ;
  onco:targets <https://onco.cc/targets/cd38/> ;
  onco:institutions <https://onco.cc/institutions/chu-lille/> ;
  onco:trials <https://onco.cc/trials/imroz/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-maia-daratumumab-rd-nejm-2019/> ;
  schema:affiliation <https://onco.cc/institutions/chu-lille/> .
